HIGHLIGHTS
- who: AKT isoform and collaborators from the Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, India Cancer Biology, Division of Cancer and Stem Cells, School of Medicine, Queen's Medical Centre, University of Nottingham have published the research: cancers and roles in cisplatin sensitivity, in the Journal: (JOURNAL)
- what: The authors investigated the expression and net effect of the individual isoforms in triple negative breast cancers and response to cisplatin treatment using cellular mice models and clinical samples. The experiments demonstrated that the expression of AKT2 isoform led to the expansion of CSCs population as . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.